• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于结直肠癌筛查的粪便样本中波形蛋白基因甲基化的定量研究。

Quantitative study of vimentin gene methylation in stool samples for colorectal cancer screening.

作者信息

Pakbaz Behfar, Jabinin Raheleh, Soltani Narjes, Ayatollahi Hossein, Farzanehfar Mohammad Reza

机构信息

Department of Gastroenterology and Pathology and Cytogenetic, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

J Adv Pharm Technol Res. 2019 Jul-Sep;10(3):121-125. doi: 10.4103/japtr.JAPTR_381_18.

DOI:10.4103/japtr.JAPTR_381_18
PMID:31334094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6621348/
Abstract

Due to importance of screening for colorectal cancer the present study was conducted and aimed at investigating the quantitative methylation of vimentin gene in stool, tumor tissue, and healthy tissue of patients with colorectal cancer (CRC) in comparison with healthy individuals. This is a case-control study in which we measures methylation of the vimentin in tumoral tissue, normal tissue and stool specimens were collected from forty-nine CRC patients as case group and stool and normal tissue specimens were collected from thirty healthy individuals as control group. There was no statistically significant difference in methylation of vimentin in normal tissue ( > 0.05) between the two groups. Moreover, the status of methylated or unmethylated vimentin gene in tumor and stool tissues in the case group was not significantly correlated with their mean age and sex ( > 0.05). This study showed that the specificity and sensitivity of vimentin methylation in stool of CRC patients are 100% and 60%, respectively. Furthermore, the methylation of vimentin in stool of CRC patients has a high-positive predictive value (100%). The results of this study suggested that methylation of the vimentin gene in the stool can be used as a specific marker for the detection and screening of CRC.

摘要

由于结直肠癌筛查的重要性,开展了本研究,旨在调查结直肠癌(CRC)患者粪便、肿瘤组织和健康组织中波形蛋白基因的定量甲基化情况,并与健康个体进行比较。这是一项病例对照研究,我们测定了49例CRC患者作为病例组的肿瘤组织、正常组织和粪便标本中波形蛋白的甲基化情况,以及30例健康个体作为对照组的粪便和正常组织标本中波形蛋白的甲基化情况。两组之间正常组织中波形蛋白的甲基化无统计学显著差异(>0.05)。此外,病例组肿瘤和粪便组织中波形蛋白基因的甲基化或未甲基化状态与它们的平均年龄和性别无显著相关性(>0.05)。本研究表明,CRC患者粪便中波形蛋白甲基化的特异性和敏感性分别为100%和60%。此外,CRC患者粪便中波形蛋白的甲基化具有较高的阳性预测值(100%)。本研究结果表明,粪便中波形蛋白基因的甲基化可作为CRC检测和筛查的特异性标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/2e56ef0a4f2a/JAPTR-10-121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/33b40d19f324/JAPTR-10-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/a59a825596f8/JAPTR-10-121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/ba6107a6e969/JAPTR-10-121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/2e56ef0a4f2a/JAPTR-10-121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/33b40d19f324/JAPTR-10-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/a59a825596f8/JAPTR-10-121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/ba6107a6e969/JAPTR-10-121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca7/6621348/2e56ef0a4f2a/JAPTR-10-121-g004.jpg

相似文献

1
Quantitative study of vimentin gene methylation in stool samples for colorectal cancer screening.用于结直肠癌筛查的粪便样本中波形蛋白基因甲基化的定量研究。
J Adv Pharm Technol Res. 2019 Jul-Sep;10(3):121-125. doi: 10.4103/japtr.JAPTR_381_18.
2
[Human stool vimentin, oncostatin M receptor and tissue factor pathway inhibitor 2 gene methylation analysis for the detection of colorectal neoplasms].[人粪便波形蛋白、抑瘤素M受体及组织因子途径抑制物2基因甲基化分析用于结直肠肿瘤检测]
Zhonghua Yi Xue Za Zhi. 2011 Sep 20;91(35):2482-4.
3
A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.一种从粪便中捕获甲基化人类DNA的新方法:对结直肠癌筛查的意义。
Clin Chem. 2007 Sep;53(9):1646-51. doi: 10.1373/clinchem.2007.086223.
4
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.粪便样本中SDC2和TFPI2甲基化作为早期检测结直肠癌的综合生物标志物
Cancer Manag Res. 2021 Apr 30;13:3601-3617. doi: 10.2147/CMAR.S300861. eCollection 2021.
5
Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.用于检测韩国患者结直肠肿瘤的粪便甲基化特异性聚合酶链反应检测法
Dis Colon Rectum. 2009 Aug;52(8):1452-9; discussion 1459-63. doi: 10.1007/DCR.0b013e3181a79533.
6
The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.粪便 DNA 甲基化在结直肠癌诊断中的重要性:一项荟萃分析。
PLoS One. 2018 Jul 19;13(7):e0200735. doi: 10.1371/journal.pone.0200735. eCollection 2018.
7
Improved fecal DNA test for colorectal cancer screening.用于结直肠癌筛查的改良粪便DNA检测
Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. doi: 10.1016/j.cgh.2006.10.006. Epub 2006 Dec 8.
8
Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer.粪便样本中SFRP1启动子的甲基化模式是早期检测结直肠癌的一个潜在标志物。
Adv Biomed Res. 2012 Dec 28;1:87. doi: 10.4103/2277-9175.105169. eCollection 2012.
9
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.磷酸酶和肌动蛋白调节因子 3 的 DNA 甲基化可检测粪便中的结直肠癌,并与 FIT 互补。
Cancer Prev Res (Phila). 2012 Mar;5(3):464-72. doi: 10.1158/1940-6207.CAPR-11-0315. Epub 2011 Dec 1.
10
Vimentin methylation as a marker for advanced colorectal carcinoma.波形蛋白甲基化作为晚期结直肠癌的标志物。
Anticancer Res. 2009 Jan;29(1):279-81.

引用本文的文献

1
The Role of Epigenetic Biomarkers as Diagnostic, Predictive and Prognostic Factors in Colorectal Cancer.表观遗传生物标志物在结直肠癌中作为诊断、预测和预后因素的作用
Cancers (Basel). 2025 Aug 12;17(16):2632. doi: 10.3390/cancers17162632.
2
DNA Methylation in Urine and Feces Indicative of Eight Major Human Cancer Types Globally.尿液和粪便中的DNA甲基化可指示全球八大主要人类癌症类型。
Life (Basel). 2025 Mar 17;15(3):482. doi: 10.3390/life15030482.
3
Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.

本文引用的文献

1
High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.高波形蛋白表达预示结直肠癌预后不良和进展:Meta 分析和 TCGA 数据库研究。
Biomed Res Int. 2018 May 31;2018:6387810. doi: 10.1155/2018/6387810. eCollection 2018.
2
Label-free quantitative proteomic analysis identifies CTNNB1 as a direct target of FOXP3 in gastric cancer cells.无标记定量蛋白质组学分析确定CTNNB1为胃癌细胞中FOXP3的直接靶点。
Oncol Lett. 2018 May;15(5):7655-7660. doi: 10.3892/ol.2018.8277. Epub 2018 Mar 15.
3
Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection.
利用遗传和表观遗传生物标志物检测结直肠癌:筛查和诊断。
J Med Life. 2024 Jan;17(1):4-14. doi: 10.25122/jml-2023-0269.
4
Exploring the role of interleukin 11 in cancer progression, patient survival, and therapeutic insights.探讨白细胞介素 11 在癌症进展、患者生存和治疗中的作用。
Mol Biol Rep. 2024 Mar 29;51(1):461. doi: 10.1007/s11033-024-09358-z.
5
Current Research on Molecular Biomarkers for Colorectal Cancer in Stool Samples.粪便样本中结直肠癌分子生物标志物的当前研究
Biology (Basel). 2023 Dec 27;13(1):15. doi: 10.3390/biology13010015.
6
Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.基于 PCR 的诊断 DNA 甲基化癌症生物标志物检测分析设计中的技术考虑因素。
Clin Epigenetics. 2022 Apr 27;14(1):56. doi: 10.1186/s13148-022-01273-z.
7
Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers?筛查结直肠癌进入新十年:表观遗传生物标志物的“咆哮 20 年代”?
Curr Oncol. 2021 Nov 20;28(6):4874-4893. doi: 10.3390/curroncol28060411.
用于结直肠癌早期检测的血浆SEPT9基因甲基化检测技术进展
World J Gastrointest Oncol. 2018 Jan 15;10(1):15-22. doi: 10.4251/wjgo.v10.i1.15.
4
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
5
DNA methylation assay for colorectal carcinoma.结直肠癌的DNA甲基化检测
Cancer Biol Med. 2017 Feb;14(1):42-49. doi: 10.20892/j.issn.2095-3941.2016.0082.
6
The significance of DNA methylation profile in metastasis-related genes for the progression of colorectal cancer.DNA甲基化谱在转移相关基因对结直肠癌进展中的意义。
Cell Mol Biol (Noisy-le-grand). 2017 Feb 28;63(2):79-87. doi: 10.14715/cmb/2017.63.2.12.
7
Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.外周血中DNA高甲基化标志物用于检测结直肠癌的诊断性能:一项荟萃分析和系统评价
PLoS One. 2016 May 9;11(5):e0155095. doi: 10.1371/journal.pone.0155095. eCollection 2016.
8
Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?在CpG岛甲基化表型面板标记中甲基化程度达一半的结直肠癌的临床病理特征与CpG岛甲基化表型高的结直肠癌的临床病理特征是否不同?
Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.
9
Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.粪便甲基化标志物对结直肠肿瘤的早期检测准确性:一项荟萃分析。
World J Gastroenterol. 2014 Oct 14;20(38):14040-50. doi: 10.3748/wjg.v20.i38.14040.
10
Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.粪便样本中异常基因甲基化对结直肠癌或腺瘤的诊断价值:一项荟萃分析。
Panminerva Med. 2015 Jun;57(2):55-64. Epub 2014 Sep 26.